lipo c with retatrutide Lipo-C Lipotropic Research Complex Retatrutide significantly improved liver health

Tirzepatide acts as a dual agonist targeting the GLP-1 and GIP receptors, while Retatrutide adds glucagon receptor activity, making it a triple agonist

Based on the populations studied in clinical trials to date, retatrutide has been investigated primarily in adults living with obesity defined as a body mass index (BMI) of 30 kg/m or above as well as in those who are overweight (BMI 27 kg/m or above) with at least one weight-related comorbidity, such as type 2 diabetes, hypertension, or dyslipidaemia

HSA and FSA cards work at checkout, with the clinic noting acceptance is not guaranteed depending on the card processor

We are here to help you achieve your health and wellness goals safely and effectively

GLP-1s arent a magic bullet cure, but rather a crutch to help people maintain healthy habits